https://www.pesquisaclinica.roche.com.br2026-03-06https://www.pesquisaclinica.roche.com.br/pt-BR/trials.html2025-06-06https://www.pesquisaclinica.roche.com.br/pt-BR/trials/uncategorized.html2019-08-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-of-ro7247669---nab-paclitaxel-compared-with-pem-15706.html2025-05-13https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-inavolisi-04316.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/the-purpose-of-this-study-is-to-evaluate-the-efficacy-a-74702.html2025-12-30https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-to-evaluate-efficacy-and-safety-of-giredestrant-50902.html2025-11-05https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-adjuvant--58545.html2025-06-30https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-of-ipatasertib-in-combination-with-paclitaxel-as-a-treat.html2025-12-30https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-comparing-atezolizumab--anti-pd-l1-antibody--in-68166.html2024-09-16https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-of-atezolizumab-and-paclitaxel-versus-placebo-and-paclit.html2025-07-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-of-the-efficacy-and-safety-of-atezolizumab-plus-chemothe.html2025-01-08https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-to-investigate-atezolizumab-and-chemotherapy-compared-wi.html2025-07-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-to-evaluate-patient-preference-and-satisfaction-26388.html2025-07-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-to-evaluate-the-efficacy-and-safety-of-atezoliz-39916.html2024-11-06https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-of-trastuzumab-emtansine-versus-trastuzumab-as-adjuvant-.html2025-07-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-phase-iii--multicenter--randomized--placebo-controlled-study-o.html2025-03-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-of-ipatasertib-plus-palbociclib-and-fulvestrant-28505.html2024-11-09https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-of-trastuzumab-emtansine--kadcyla--plus-pertuzu-91245.html2025-12-22https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-of-pertuzumab-in-combination-with-trastuzumab---50542.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-safety-and-tolerability-study-of-assisted-and-self-ad-95353.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-gdc-9545--37336.html2025-06-30https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-gdc-9545--28702.html2025-08-04https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-evaluating-the-efficacy--safety--and-pharmacoki-19834.html2025-07-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-of-trastuzumab-emtansine-in-participants-with-h-49753.html2025-12-22https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-inavolisi-81795.html2025-10-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/leukemia/a-study-to-compare-the-efficacy-and-safety-of-obinutuzu-46860.html2025-08-04https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/oc/a-study-of-atezolizumab-versus-placebo-in-combination-with-pacli.html2025-07-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/crc/a-study-of-biomarker-driven-therapy-in-metastatic-color-93743.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/cca/a-study-of-tiragolumab-plus-atezolizumab-and-atezolizum-32500.html2026-01-16https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/pv.html2019-08-22https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bladder-cancer/study-of-atezolizumab-as-monotherapy-and-in-combination-with-pla.html2025-07-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bladder-cancer/a-study-of-atezolizumab-versus-placebo-as-adjuvant-ther-94959.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/bladder-cancer/a-study-of-ro7247669-alone-or-in-combination-with-tirag-35445.html2025-02-07https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-atezolizumab-compared-with-chemotherapy-in-treatment-.html2025-07-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-to-evaluate-efficacy-and-safety-of-multiple-targeted-the.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-atezolizumab--tecentriq--to-investigate-long-term-saf.html2025-01-24https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-carboplatin-plus-etoposide-with-or-without-atezolizum.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-atezolizumab-plus-carboplatin-and-etoposide--78663.html2025-09-19https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-tiragolumab-in-combination-with-atezolizumab-44503.html2025-09-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-comparing-alectinib-with-crizotinib-in-treatmen-47622.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-atezolizumab-and-tiragolumab-compared-with-d-48756.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-atezolizumab-in-combination-with-carboplatin-26891.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-atezolizumab-in-combination-with-carboplatin-09998.html2025-07-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-to-investigate-the-pharmacokinetics--efficacy---50110.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-tiragolumab-in-combination-with-atezolizumab-98469.htmlhttps://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-atezolizumab-compared-with-docetaxel-in-part-43570.html2025-03-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-to-compare-the-efficacy-and-safety-of-entrectin-60665.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-to-evaluate-participant-and-healthcare-professi-70557.html2024-11-22https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-clinical-trial-to-look-at-how-well-atezolizumab-works--and-how.html2024-09-13https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-ro7247669-plus-platinum-based-chemotherapy-v-60649.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-evaluating-the-safety--activity--and-pharmacoki-06656.html2025-09-19https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-evaluating-the-efficacy-and-safety-of-multiple--44971.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-of-tiragolumab-plus-atezolizumab-compared-with--98034.html2025-01-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-evaluating-the-efficacy-and-safety-of-divarasib-87627.html2025-09-24https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-to-see-how-well-and-how-safely-different-treatm-24461.html2025-05-14https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/lung-cancer/a-study-evaluating-the-efficacy-and-safety-of-divarasib-53110.html2025-11-06https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/multiple-myeloma.html2019-08-28https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/rcc/a-study-of-atezolizumab-in-combination-with-bevacizumab-07419.html2025-07-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/skin-cancer/cobimetinib--targeted-therapy--plus-atezolizumab--immunotherapy-.html2026-03-25https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/skin-cancer/a-study-of-cobimetinib-plus-atezolizumab-versus-pembrolizumab-in.html2025-03-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/skin-cancer/a-study-evaluating-the-safety-and-efficacy-of-cobimetin-52731.html2025-07-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/hepatocellular-carcinoma/a-study-of-atezolizumab-with-lenvatinib-or-sorafenib-ve-22252.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/Head_and_Neck_Cancer/a-study-of-atezolizumab--antipd-l1-antibody--as-adjuvant-therapy.html2025-07-03https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/Brain_Tumor.html2019-08-28https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/pancreatic-cancer.html2019-08-28https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/a-safety-and-efficacy-extension-study-of-pertuzumab-in-patients-.html2024-09-25https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/an-extension--rollover--study-of-vemurafenib-in-participants-wit.html2025-03-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/prostate-cancer/ipatasertib-plus-abiraterone-plus-prednisone-prednisolone--relat.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/gc/a-study-of-pertuzumab-in-combination-with-trastuzumab-a-09628.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/a-study-of-atezolizumab-in-locally-advanced-or-metastat-72736.html2025-12-22https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/an-extension-study-to-provide-continued-bevacizumab-therapy-to-p.html2024-08-30https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/fmi.html2023-05-10https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/non-hodgkins-lymphoma/an-open-label--single-arm-study-of-obinutuzumab-short-d-96747.html2024-08-30https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/non-hodgkins-lymphoma/a-study-comparing-maintenance-subcutaneous-rituximab-wi-80076.html2025-03-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/non-hodgkins-lymphoma/a-study-comparing-the-efficacy-and-safety-of-polatuzumab-vedotin.html2025-06-30https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-efficacy-and-safety-of-mosunetuzumab-27695.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-glofitamab-as-a-single-agent-vs--in-75996.html2025-09-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/non-hodgkins-lymphoma/an-open-label-study-comparing-glofitamab-and-polatuzuma-51322.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-glofitamab---chemoimmunotherapy-in--23052.html2025-11-13https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/endometrial-cancer.html2025-09-22https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/a-study-of-avastin--bevacizumab--in-combination-with-st-82381.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/a-study-in-participants-previously-enrolled-in-a-genentech-and-o.html2025-07-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/a-study-in-patients-previously-enrolled-in-a-genentech--39726.html2025-07-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/a-phase-ii-randomized-study-comparing-the-efficacy-and-safety-of.html2026-02-19https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/high-grade-glioma.html2020-09-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/solid-tumors/tumor-agnostic-precision-immuno-oncology-and-somatic-ta-50851.html2025-10-23https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/solid-tumors/an-open-label-dose-escalation-study-to-evaluate-xmab243-88679.html2025-07-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/solid-tumors/screening-study-for-participants-with-malignant-tumors-95723.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/esophageal-squamous-cell-carcinoma.html2020-10-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cancer/melanoma/a-study-of-multiple-doses-of-ro7247669-in-participants--81417.html2025-01-22https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/giant-cell-arteritis.html2019-12-18https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/jia/a-study-of-subcutaneously-administered-tocilizumab-in-p-36947.html2025-12-22https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/jia/a-study-of-subcutaneously--sc--administered-tocilizumab-80633.html2025-12-22https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/ra/a-study-to-evaluate-the-long-term-safety-and-efficacy-of-gdc-085.html2025-08-04https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/ra/safety-and-efficacy-study-of-gdc-0853-compared-with-pla-80091.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/sjogren-s-syndrome.html2019-08-28https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/ulcerative-colitis/a-study-comparing-the-efficacy-and-safety-of-etrolizumab-with-ad.html2026-01-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/ulcerative-colitis/a-study-of-the-efficacy-and-safety-of-etrolizumab-in-ulcerative-.html2026-01-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/ulcerative-colitis/study-for-participants-with-ulcerative-colitis-previously-enroll.html2024-10-24https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/ulcerative-colitis/a-study-of-the-efficacy-and-safety-of-etrolizumab-treatment-in-m.html2025-12-07https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/ulcerative-colitis/a-study-comparing-the-efficacy-and-safety-of-etrolizumab-with-ad0.html2026-01-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/crohn-s-disease/a-study-to-assess-whether-etrolizumab-is-a-safe-and-effective-tr.html2025-02-20https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/crohn-s-disease/a-study-to-assess-the-efficacy-and-safety-of-induction--32899.html2025-11-06https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/crohn-s-disease/a-study-to-assess-the-efficacy-and-safety-of-induction--94939.html2025-10-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/sle/study-of-the-safety-and-efficacy-of-gdc-0853-in-participants-wit.html2025-07-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/sle/a-study-to-evaluate-the-efficacy-and-safety-of-obinutuz-62318.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/an-extension-study-of-gdc-0853-in-participants-with-moderate-to-.html2025-03-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/systemic-sclerosis.html2019-08-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/ibd/a-study-to-assess-the-efficacy-and-safety-of-induction--79083.html2025-11-07https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/a-study-to-evaluate-the-efficacy-and-safety-of-rituxima-33498.html2026-04-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/ln/a-study-to-evaluate-the-efficacy-and-safety-of-obinutuz-33293.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/ln/a-study-to-evaluate-the-efficacy--safety--and-pharmacok-25573.html2025-11-03https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/pnh/a-phase-iii-study-evaluating-the-efficacy-and-safety-of-15078.html2025-07-30https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/pnh/a-study-evaluating-the-efficacy-and-safety-of-crovalima-16124.html2025-07-30https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/myasthenia-gravis-iab/a-study-to-evaluate-efficacy--safety--pharmacokinetics--13414.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/mog-antibody-disease/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-94806.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-ocrelizumab-treatment-in-participants-with-p.html2025-12-11https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/multiple-sclerosis/a-pharmacokinetics--pk---pharmacodynamics--pd---safety--83549.html2025-10-21https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-assess-bioequivalence-of-two-subcutaneous--s-18385.html2025-11-20https://www.pesquisaclinica.roche.com.br/pt-BR/trials/autoimmune-disorder/autoimmune-encephalitis/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-99237.html2025-11-06https://www.pesquisaclinica.roche.com.br/pt-BR/trials/eye-disorder/dme/a-study-to-evaluate-the-efficacy-and-safety-of-ro686746-59371.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/eye-disorder/glaucoma.html2019-08-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/eye-disorder/amd/a-study-to-evaluate-the-long-term-safety-and-tolerabili-60381.html2025-07-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/eye-disorder/amd/a-study-of-the-efficacy--safety--and-pharmacokinetics-o-88020.html2025-05-14https://www.pesquisaclinica.roche.com.br/pt-BR/trials/eye-disorder/wamd/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-82370.html2024-09-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/eye-disorder/uveitic-macular-edema/a-study-to-investigate-ro7200220-in-participants-with-u-27483.html2025-03-26https://www.pesquisaclinica.roche.com.br/pt-BR/trials/muscle-and-peripheral-nerve-disease/sma/a-study-to-investigate-the-safety--tolerability--pharmacokinetic1.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/muscle-and-peripheral-nerve-disease/sma/a-study-of-risdiplam-in-infants-with-genetically-diagno-31840.html2025-08-04https://www.pesquisaclinica.roche.com.br/pt-BR/trials/muscle-and-peripheral-nerve-disease/dmd.html2019-08-28https://www.pesquisaclinica.roche.com.br/pt-BR/trials/muscle-and-peripheral-nerve-disease/muscular-dystrophy.html2019-08-28https://www.pesquisaclinica.roche.com.br/pt-BR/trials/infectious-diseases/influenza/study-to-assess-efficacy-and-safety-of-baloxavir-marbox-94137.html2025-07-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/infectious-diseases/bacterial-infection.html2019-08-28https://www.pesquisaclinica.roche.com.br/pt-BR/trials/infectious-diseases/covid-19-pneumonia/a-study-to-evaluate-the-efficacy-and-safety-of-tocilizu-42486.html2025-12-22https://www.pesquisaclinica.roche.com.br/pt-BR/trials/infectious-diseases/covid-19-pneumonia/a-study-to-evaluate-the-safety-and-efficacy-of-mstt1041-69681.html2025-07-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/infectious-diseases/covid-19-pneumonia/study-to-evaluate-the-effects-of-ro7496998--at-527--in--47025.html2025-07-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/infectious-diseases/covid-19-pneumonia/a-six-month-follow-up-study-of-participants-with-corona-57262.html2025-07-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/neurodegenerative-disorder/ad/a-study-of-crenezumab-versus-placebo-to-evaluate-the-efficacy-an.html2025-07-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/neurodegenerative-disorder/ad/efficacy-and-safety-study-of-gantenerumab-in-participants-with-e.html2024-08-30https://www.pesquisaclinica.roche.com.br/pt-BR/trials/neurodegenerative-disorder/ad/a-study-of-gantenerumab-in-participants-with-prodromal--48625.html2024-08-31https://www.pesquisaclinica.roche.com.br/pt-BR/trials/neurodegenerative-disorder/als.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/neurodegenerative-disorder/pd.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/neurodegenerative-disorder/multiple-sclerosis/this-is-an-extension-study-of-the-roche-p-trial-to-inve-91061.html2024-09-16https://www.pesquisaclinica.roche.com.br/pt-BR/trials/neurodegenerative-disorder/hd.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/neurodevelopmental-disorder.html2019-08-28https://www.pesquisaclinica.roche.com.br/pt-BR/trials/neurodevelopmental-disorder/autism-spectrum-disorder.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/psychiatric-disorder.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/psychiatric-disorder/schizophrenia.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/respiratory-disorder.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/respiratory-disorder/ipf.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/respiratory-disorder/asthma.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/healthy-volunteers.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/kidney-disorder/renal-failure.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/kidney-disorder/iga-nephropathy/a-study-to-evaluate-the-efficacy-and-safety-of-ro743465-06097.html2025-10-17https://www.pesquisaclinica.roche.com.br/pt-BR/trials/metabolic-disorder.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/metabolic-disorder/t1d.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/metabolic-disorder/t2d.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/metabolic-disorder/Liver_Failure.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cardiovascular-disorder.html2019-08-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/cardiovascular-disorder/AIS.html2019-08-01https://www.pesquisaclinica.roche.com.br/pt-BR/trials/hematologic-diseases/myelodysplastic-syndrome.html2019-08-29https://www.pesquisaclinica.roche.com.br/pt-BR/trials/hematologic-diseases/Hemophilia/hemophilia-a/a-study-to-evaluate-the-safety-and-tolerability-of-prophylactic-.html2024-08-30https://www.pesquisaclinica.roche.com.br/pt-BR/trials/blood-disorder/sickle-cell-disease/a-study-evaluating-the-efficacy--safety--pharmacokineti-50959.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/blood-disorder/sickle-cell-disease/a-study-evaluating-the-safety--pharmacokinetics--pharma-03990.html2025-03-27https://www.pesquisaclinica.roche.com.br/pt-BR/trials/blood-disorder/sindrome-hemolitica-uremica-atipica.html2022-11-02https://www.pesquisaclinica.roche.com.br/pt-BR/trials/blood-disorder/atypical-hemolytic-uremic-syndrome/a-study-evaluating-the-efficacy--safety--pharmacokineti-294061.html2025-09-10https://www.pesquisaclinica.roche.com.br/pt-BR/faq.html2024-02-28https://www.pesquisaclinica.roche.com.br/pt-BR/faq/what-is-a-clinical-trial.html2024-11-13https://www.pesquisaclinica.roche.com.br/pt-BR/faq/why-should-i-consider-taking-part-in-a-clinical-trial.html2024-11-13https://www.pesquisaclinica.roche.com.br/pt-BR/faq/roche-in-clinical-trials.html2024-11-14https://www.pesquisaclinica.roche.com.br/pt-BR/faq/conheca-os-estudos-roche.html2021-06-17https://www.pesquisaclinica.roche.com.br/pt-BR/faq/what-is-an-observational-trial.html2023-02-24https://www.pesquisaclinica.roche.com.br/pt-BR/faq/advancing-inclusive-research.html2023-02-24https://www.pesquisaclinica.roche.com.br/pt-BR/error.html2019-08-01https://www.pesquisaclinica.roche.com.br/pt-BR/error/404.html2024-10-18https://www.pesquisaclinica.roche.com.br/pt-BR/error/403.html2024-10-18https://www.pesquisaclinica.roche.com.br/pt-BR/error/500.html2024-10-18https://www.pesquisaclinica.roche.com.br/pt-BR/privacy-policy.html2019-08-01https://www.pesquisaclinica.roche.com.br/pt-BR/glossary-terms.html2025-12-29https://www.pesquisaclinica.roche.com.br/pt-BR/About.html2019-10-14https://www.pesquisaclinica.roche.com.br/pt-BR/sitemap.html2019-08-01https://www.pesquisaclinica.roche.com.br/pt-BR/Nota-COVID-19-Brasil.html2023-02-24https://www.pesquisaclinica.roche.com.br/pt-BR/disease-area-overview.html2021-02-26https://www.pesquisaclinica.roche.com.br/pt-BR/Iniciativas-que-o-time-de-pesquisa-clinica-roche-brasil-ofereceu-para-os-Investigadores-e-centros-de-pesquisa-clinica-durante-a-pandemia.html2020-09-28https://www.pesquisaclinica.roche.com.br/pt-BR/new-solr-search.html2024-02-16